The vector of anti-FKBP5 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human FKBP5. The T cells are genetically modified through transduction with a lentiviral vector expressing FKBP linked to CD3-zeta signaling domains. And the vector product was designed for the treatment of leukemia.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-CQ1015||Anti-FKBP5 (CBXF-2240) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-CQ4435||Anti-FKBP5 (Hi51B) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ4436||Anti-FKBP5 (CBXF-0716) h(CD28-CD3ζ) CAR, pCDCAR1|
|DMAb-1013-CQ||Mouse Anti-FKBP5 DNA-encoded mAb (Clone CBXF-1973), pVAX1|
|CAR-T-2-L409-4G||FKBP5 h(FKBP-FcεR) CAR, [T]|
|DMAb-1015-CQ||Rabbit Anti-FKBP5 DNA-encoded mAb (Clone CBXF-2240), pVAX1|
|CAR-T-3-L409-2XZ||FKBP5 h(CD28-OX40-CD3ζ) CAR, [T]|
|CAR-CQ4437||Anti-FKBP5 (CBXF-1973) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-T-2-L409-4Z||FKBP5 h(FKBP-CD3ζ) CAR, [T]|
|CAR-T-2-L409-CZ||FKBP5 h(b2c-CD3ζ) CAR, [T]|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved